Paclitaxel (Taxol Equivalent) - for use in research only

Invitrogen offers paclitaxel for research purposes only at a purity of >98% by HPLC. Paclitaxel, formerly referred to as taxol in some scientific literature, is the approved generic name for the anticancer pharmaceutical Taxol (a registered trademark of Bristol-Myers Squibb Co). Paclitaxel promotes tubulin assembly, producing aggregates that cannot be depolymerized by dilution, calcium ions, cold or a number of microtubule-disrupting drugs. Cultured cells treated with paclitaxel are blocked in the G2 and M phases of the cell cycle.